Anthropic Surpasses OpenAI: A Financial Update
In this episode, we provide an update on how Anthropic has surpassed OpenAI in revenue. Join us for an analysis of what this means moving forward.See Privacy Policy at https://art19.com/privacy and Ca...
20 Apr 14min
Claude’s Design and Its Market Opportunities
In this episode, we analyze the market opportunities presented by Claude’s design. Understand how businesses can leverage AI advancements.See Privacy Policy at https://art19.com/privacy and California...
17 Apr 14min
Anthropic Ships Opus 4.7, $2B With No Product & Google AI Deals
Anthropic dropped Claude Opus 4.7 today, but the bigger story is the model they didn't release. We break down Project Glasswing, why Mythos stays locked up, and what it signals about where frontier AI...
16 Apr 14min
Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human
Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug development. We break down what this healthcare AI l...
15 Apr 15min
Altman Gets Molotov Cocktail, Zuckerberg Creates AI Clone
In this episode, we explore groundbreaking developments in the tech world, including Mark Zuckerberg's creation of an AI version of himself and Apple's revolutionary smart glasses. We also discuss the...
13 Apr 15min
Meta's New Model, Gemini 4, OpenAI Proposes AI Policy
Today we (really just me lol) talk about Google's launch of Gemini 4, a groundbreaking open-source model. We also discuss the implications of Eli Lilly's powerful new supercomputer for drug developmen...
9 Apr 15min
Anthropic's Mythos Found Millions of Security Vulnerabilities
In this episode, we explore Anthropic's ambitious Project Glasswing, aimed at securing critical software vulnerabilities with the powerful Claude Mythos Preview model. With a $100 million pledge to ma...
7 Apr 11min
Q1 2026 Venture Funding Hits $300B Record
In this episode, we examine the astonishing $300 billion venture funding in Q1 2026, with 80% allocated to AI startups. We also discuss the implications of new AI regulations, healthcare breakthroughs...
6 Apr 16min
